Cargando…

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging

We performed a metabolomics study using liquid chromatography-mass spectrometry (LC-MS) combined with multivariate data analysis (MVDA) to discriminate global urine profiles in urine samples from esophageal squamous cell carcinoma (ESCC) patients and healthy controls (NC). Our work evaluated the fea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jing, Chen, Yanhua, Zhang, Ruiping, He, Jiuming, Song, Yongmei, Wang, Jingbo, Wang, Huiqing, Wang, Luhua, Zhan, Qimin, Abliz, Zeper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057114/ https://www.ncbi.nlm.nih.gov/pubmed/27725730 http://dx.doi.org/10.1038/srep35010

Ejemplares similares

Spatially resolved metabolomics to discover tumor-associated metabolic alterations
por: Sun, Chenglong, et al.
Publicado: (2019)

A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS
por: Liu, Dan, et al.
Publicado: (2020)

Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets
por: Jin, Bo, et al.
Publicado: (2023)

Molecular Pathological Diagnosis of Thyroid Tumors Using Spatially Resolved Metabolomics
por: Huang, Luojiao, et al.
Publicado: (2022)

Rapid and sensitive liquid chromatography–tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5,5′-oxydimethylenebis (2-furfural) in traditional Chinese medicine injections
por: Zang, Qingce, et al.
Publicado: (2018)

Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
por: Li, Limei, et al.
Publicado: (2023)

Evaluation of the tumor-targeting efficiency and intratumor heterogeneity of anticancer drugs using quantitative mass spectrometry imaging
por: Zhang, Jin, et al.
Publicado: (2020)

Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging
por: Mao, Xinxin, et al.
Publicado: (2023)

Rewiring of purine metabolism in response to acidosis stress in glioma stem cells
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Application of imaging mass spectrometry for the molecular diagnosis of human breast tumors
por: Mao, Xinxin, et al.
Publicado: (2016)

A Sensitive and Wide Coverage Ambient Mass Spectrometry Imaging Method for Functional Metabolites Based Molecular Histology
por: He, Jiuming, et al.
Publicado: (2018)

Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma
por: Guo, Shichao, et al.
Publicado: (2022)

In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging
por: Li, Tiegang, et al.
Publicado: (2015)

Ratiometric Mass Spectrometry Imaging for Stain-Free Delineation of Ischemic Tissue and Spatial Profiling of Ischemia-Related Molecular Signatures
por: Wang, Zixuan, et al.
Publicado: (2021)

Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging
por: Wang, Zhonghua, et al.
Publicado: (2021)

In situ metabolomics in nephrotoxicity of aristolochic acids based on air flow-assisted desorption electrospray ionization mass spectrometry imaging
por: Wang, Zhonghua, et al.
Publicado: (2020)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)

Comparison of Local Metabolic Changes in Diabetic Rodent Kidneys Using Mass Spectrometry Imaging
por: Zhang, Xin, et al.
Publicado: (2023)

Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment
por: Zhao, Zitong, et al.
Publicado: (2023)

Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging
por: Zhang, Min, et al.
Publicado: (2019)

MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology
por: Sun, Guogui, et al.
Publicado: (2018)

A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
por: Bi, Nan, et al.
Publicado: (2014)

Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma
por: Min, Qingjie, et al.
Publicado: (2021)

BAALC‐AS1/G3BP2/c‐Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma
por: Zhang, Hongyue, et al.
Publicado: (2021)

MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2021)

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

miR-875-5p exerts tumor-promoting function via down-regulation of CAPZA1 in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2021)

Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus
por: Davis, Vanessa W, et al.
Publicado: (2012)

Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2018)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)
por: Zhao, Yue, et al.
Publicado: (2014)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2021)

An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma
por: Wang, Qiyan, et al.
Publicado: (2015)

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer
por: Wang, Guangchao, et al.
Publicado: (2020)

The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2022)

Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma
por: Gong, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ahkkj1qtifv2n4td6mm218k8pa